Literature DB >> 2670776

Hormonal therapy of prostate cancer: choosing among several available options.

R J Santen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2670776     DOI： 10.1111/j.1365-2605.1989.tb01300.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN： 0105-6263


× No keyword cloud information.
  1 in total

1.  The gonadotropin-releasing hormone (GnRH) agonist-induced initial rise of bioactive LH and testosterone can be blunted in a dose-dependent manner by GnRH antagonist in the non-human primate.

Authors:  O P Sharma; G F Weinbauer; H M Behre; E Nieschlag
Journal:  Urol Res       Date:  1992
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.